share_log

德琪醫藥-B:自願公告 ATG-008聯合抗PD-1單抗藥物治療複發性╱ 轉移性宮頸癌的臨床療效結果令人鼓舞

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT ENCOURAGING CLINICAL EFFICACY RESULTS OF ATG-008 IN COMBINATION WITH PD-1 ANTIBODY IN RELAPSED/METASTATIC CERVICAL CANCER

Nov 15, 2022 03:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more